Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2025-2031
According to this study, the global Adoptive Cell Transfer Therapy market size will reach US$ million by 2031.
United States market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Adoptive Cell Transfer Therapy players cover Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Adoptive Cell Transfer Therapy Industry Forecast” looks at past sales and reviews total world Adoptive Cell Transfer Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Adoptive Cell Transfer Therapy sales for 2025 through 2031. With Adoptive Cell Transfer Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cell Transfer Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cell Transfer Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adoptive Cell Transfer Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cell Transfer Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cell Transfer Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cell Transfer Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Transfer Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Adoptive Cell Transfer Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Adoptive Cell Transfer Therapy players cover Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Adoptive Cell Transfer Therapy Industry Forecast” looks at past sales and reviews total world Adoptive Cell Transfer Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Adoptive Cell Transfer Therapy sales for 2025 through 2031. With Adoptive Cell Transfer Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cell Transfer Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cell Transfer Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adoptive Cell Transfer Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cell Transfer Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cell Transfer Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cell Transfer Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Transfer Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- NK
- LAK
- DC
- CIK
- CTL
- TIL
- TCR-T
- CAR-T
- Acute Lymphocytic Leukemia
- NHL
- Melanoma
- Bladder Cancer
- Lung Cancer
- Head and Neck Cancer
- Multiple Myeloma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Kite Pharma
- Pfizer
- Juno Therapeutics
- Celgene Corporation
- CARsgen Therapeutics
- Sorrento Therapeutics
- Legend Biotech
- Atara Biotherapeutics
- Aurora Biopharma
- Autolus Therapeutics PLC
- Bluebird
- Carina Biotech
- Athenex
- Xiangxue Pharmaceutical (Xiangxue Precision)
- Hengrui Yuanzheng
- Eureka Therapeutics
- WuXi Juno
- Shenzhen Inno Immunity
- Shenzhen Binde Bio
- Kerui Bio
- Adaptimmune
- Altor Bioscience Corporation
- Cellectis
- Takara Bio
- Unum Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size (2020-2031)
2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Adoptive Cell Transfer Therapy by Country/Region (2020, 2024 & 2031)
2.2 Adoptive Cell Transfer Therapy Segment by Type
2.2.1 NK
2.2.2 LAK
2.2.3 DC
2.2.4 CIK
2.2.5 CTL
2.2.6 TIL
2.2.7 TCR-T
2.2.8 CAR-T
2.3 Adoptive Cell Transfer Therapy Market Size by Type
2.3.1 Adoptive Cell Transfer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
2.4 Adoptive Cell Transfer Therapy Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 NHL
2.4.3 Melanoma
2.4.4 Bladder Cancer
2.4.5 Lung Cancer
2.4.6 Head and Neck Cancer
2.4.7 Multiple Myeloma
2.4.8 Other
2.5 Adoptive Cell Transfer Therapy Market Size by Application
2.5.1 Adoptive Cell Transfer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
3 ADOPTIVE CELL TRANSFER THERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Player
3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Player (2020-2025)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELL TRANSFER THERAPY BY REGION
4.1 Adoptive Cell Transfer Therapy Market Size by Region (2020-2025)
4.2 Global Adoptive Cell Transfer Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.4 APAC Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.5 Europe Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2020-2025)
6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2020-2025)
8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELL TRANSFER THERAPY MARKET FORECAST
10.1 Global Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.1.2 Americas Adoptive Cell Transfer Therapy Forecast
10.1.3 APAC Adoptive Cell Transfer Therapy Forecast
10.1.4 Europe Adoptive Cell Transfer Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast
10.2 Americas Adoptive Cell Transfer Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Adoptive Cell Transfer Therapy Forecast
10.2.2 Canada Market Adoptive Cell Transfer Therapy Forecast
10.2.3 Mexico Market Adoptive Cell Transfer Therapy Forecast
10.2.4 Brazil Market Adoptive Cell Transfer Therapy Forecast
10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.3.1 China Adoptive Cell Transfer Therapy Market Forecast
10.3.2 Japan Market Adoptive Cell Transfer Therapy Forecast
10.3.3 Korea Market Adoptive Cell Transfer Therapy Forecast
10.3.4 Southeast Asia Market Adoptive Cell Transfer Therapy Forecast
10.3.5 India Market Adoptive Cell Transfer Therapy Forecast
10.3.6 Australia Market Adoptive Cell Transfer Therapy Forecast
10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Adoptive Cell Transfer Therapy Forecast
10.4.2 France Market Adoptive Cell Transfer Therapy Forecast
10.4.3 UK Market Adoptive Cell Transfer Therapy Forecast
10.4.4 Italy Market Adoptive Cell Transfer Therapy Forecast
10.4.5 Russia Market Adoptive Cell Transfer Therapy Forecast
10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Adoptive Cell Transfer Therapy Forecast
10.5.2 South Africa Market Adoptive Cell Transfer Therapy Forecast
10.5.3 Israel Market Adoptive Cell Transfer Therapy Forecast
10.5.4 Turkey Market Adoptive Cell Transfer Therapy Forecast
10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2026-2031)
10.7 Global Adoptive Cell Transfer Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Adoptive Cell Transfer Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered
11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Information
11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Juno Therapeutics Main Business Overview
11.4.5 Juno Therapeutics Latest Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Information
11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celgene Corporation Main Business Overview
11.5.5 Celgene Corporation Latest Developments
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Information
11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 CARsgen Therapeutics Main Business Overview
11.6.5 CARsgen Therapeutics Latest Developments
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Information
11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sorrento Therapeutics Main Business Overview
11.7.5 Sorrento Therapeutics Latest Developments
11.8 Legend Biotech
11.8.1 Legend Biotech Company Information
11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Legend Biotech Main Business Overview
11.8.5 Legend Biotech Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Information
11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Aurora Biopharma Main Business Overview
11.10.5 Aurora Biopharma Latest Developments
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Information
11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Autolus Therapeutics PLC Main Business Overview
11.11.5 Autolus Therapeutics PLC Latest Developments
11.12 Bluebird
11.12.1 Bluebird Company Information
11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered
11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bluebird Main Business Overview
11.12.5 Bluebird Latest Developments
11.13 Carina Biotech
11.13.1 Carina Biotech Company Information
11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Carina Biotech Main Business Overview
11.13.5 Carina Biotech Latest Developments
11.14 Athenex
11.14.1 Athenex Company Information
11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered
11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Athenex Main Business Overview
11.14.5 Athenex Latest Developments
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Information
11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Hengrui Yuanzheng Main Business Overview
11.16.5 Hengrui Yuanzheng Latest Developments
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Information
11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Eureka Therapeutics Main Business Overview
11.17.5 Eureka Therapeutics Latest Developments
11.18 WuXi Juno
11.18.1 WuXi Juno Company Information
11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 WuXi Juno Main Business Overview
11.18.5 WuXi Juno Latest Developments
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Information
11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Shenzhen Inno Immunity Main Business Overview
11.19.5 Shenzhen Inno Immunity Latest Developments
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Information
11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Shenzhen Binde Bio Main Business Overview
11.20.5 Shenzhen Binde Bio Latest Developments
11.21 Kerui Bio
11.21.1 Kerui Bio Company Information
11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Kerui Bio Main Business Overview
11.21.5 Kerui Bio Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Information
11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Altor Bioscience Corporation Main Business Overview
11.23.5 Altor Bioscience Corporation Latest Developments
11.24 Cellectis
11.24.1 Cellectis Company Information
11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered
11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Cellectis Main Business Overview
11.24.5 Cellectis Latest Developments
11.25 Takara Bio
11.25.1 Takara Bio Company Information
11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Takara Bio Main Business Overview
11.25.5 Takara Bio Latest Developments
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Information
11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Unum Therapeutics Main Business Overview
11.26.5 Unum Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size (2020-2031)
2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Adoptive Cell Transfer Therapy by Country/Region (2020, 2024 & 2031)
2.2 Adoptive Cell Transfer Therapy Segment by Type
2.2.1 NK
2.2.2 LAK
2.2.3 DC
2.2.4 CIK
2.2.5 CTL
2.2.6 TIL
2.2.7 TCR-T
2.2.8 CAR-T
2.3 Adoptive Cell Transfer Therapy Market Size by Type
2.3.1 Adoptive Cell Transfer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
2.4 Adoptive Cell Transfer Therapy Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 NHL
2.4.3 Melanoma
2.4.4 Bladder Cancer
2.4.5 Lung Cancer
2.4.6 Head and Neck Cancer
2.4.7 Multiple Myeloma
2.4.8 Other
2.5 Adoptive Cell Transfer Therapy Market Size by Application
2.5.1 Adoptive Cell Transfer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
3 ADOPTIVE CELL TRANSFER THERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Player
3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Player (2020-2025)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELL TRANSFER THERAPY BY REGION
4.1 Adoptive Cell Transfer Therapy Market Size by Region (2020-2025)
4.2 Global Adoptive Cell Transfer Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.4 APAC Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.5 Europe Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2020-2025)
6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2020-2025)
8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELL TRANSFER THERAPY MARKET FORECAST
10.1 Global Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.1.2 Americas Adoptive Cell Transfer Therapy Forecast
10.1.3 APAC Adoptive Cell Transfer Therapy Forecast
10.1.4 Europe Adoptive Cell Transfer Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast
10.2 Americas Adoptive Cell Transfer Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Adoptive Cell Transfer Therapy Forecast
10.2.2 Canada Market Adoptive Cell Transfer Therapy Forecast
10.2.3 Mexico Market Adoptive Cell Transfer Therapy Forecast
10.2.4 Brazil Market Adoptive Cell Transfer Therapy Forecast
10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.3.1 China Adoptive Cell Transfer Therapy Market Forecast
10.3.2 Japan Market Adoptive Cell Transfer Therapy Forecast
10.3.3 Korea Market Adoptive Cell Transfer Therapy Forecast
10.3.4 Southeast Asia Market Adoptive Cell Transfer Therapy Forecast
10.3.5 India Market Adoptive Cell Transfer Therapy Forecast
10.3.6 Australia Market Adoptive Cell Transfer Therapy Forecast
10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Adoptive Cell Transfer Therapy Forecast
10.4.2 France Market Adoptive Cell Transfer Therapy Forecast
10.4.3 UK Market Adoptive Cell Transfer Therapy Forecast
10.4.4 Italy Market Adoptive Cell Transfer Therapy Forecast
10.4.5 Russia Market Adoptive Cell Transfer Therapy Forecast
10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Adoptive Cell Transfer Therapy Forecast
10.5.2 South Africa Market Adoptive Cell Transfer Therapy Forecast
10.5.3 Israel Market Adoptive Cell Transfer Therapy Forecast
10.5.4 Turkey Market Adoptive Cell Transfer Therapy Forecast
10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2026-2031)
10.7 Global Adoptive Cell Transfer Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Adoptive Cell Transfer Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered
11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Information
11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Juno Therapeutics Main Business Overview
11.4.5 Juno Therapeutics Latest Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Information
11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celgene Corporation Main Business Overview
11.5.5 Celgene Corporation Latest Developments
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Information
11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 CARsgen Therapeutics Main Business Overview
11.6.5 CARsgen Therapeutics Latest Developments
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Information
11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sorrento Therapeutics Main Business Overview
11.7.5 Sorrento Therapeutics Latest Developments
11.8 Legend Biotech
11.8.1 Legend Biotech Company Information
11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Legend Biotech Main Business Overview
11.8.5 Legend Biotech Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Information
11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Aurora Biopharma Main Business Overview
11.10.5 Aurora Biopharma Latest Developments
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Information
11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Autolus Therapeutics PLC Main Business Overview
11.11.5 Autolus Therapeutics PLC Latest Developments
11.12 Bluebird
11.12.1 Bluebird Company Information
11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered
11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bluebird Main Business Overview
11.12.5 Bluebird Latest Developments
11.13 Carina Biotech
11.13.1 Carina Biotech Company Information
11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Carina Biotech Main Business Overview
11.13.5 Carina Biotech Latest Developments
11.14 Athenex
11.14.1 Athenex Company Information
11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered
11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Athenex Main Business Overview
11.14.5 Athenex Latest Developments
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Information
11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Hengrui Yuanzheng Main Business Overview
11.16.5 Hengrui Yuanzheng Latest Developments
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Information
11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Eureka Therapeutics Main Business Overview
11.17.5 Eureka Therapeutics Latest Developments
11.18 WuXi Juno
11.18.1 WuXi Juno Company Information
11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 WuXi Juno Main Business Overview
11.18.5 WuXi Juno Latest Developments
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Information
11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Shenzhen Inno Immunity Main Business Overview
11.19.5 Shenzhen Inno Immunity Latest Developments
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Information
11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Shenzhen Binde Bio Main Business Overview
11.20.5 Shenzhen Binde Bio Latest Developments
11.21 Kerui Bio
11.21.1 Kerui Bio Company Information
11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Kerui Bio Main Business Overview
11.21.5 Kerui Bio Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Information
11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Altor Bioscience Corporation Main Business Overview
11.23.5 Altor Bioscience Corporation Latest Developments
11.24 Cellectis
11.24.1 Cellectis Company Information
11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered
11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Cellectis Main Business Overview
11.24.5 Cellectis Latest Developments
11.25 Takara Bio
11.25.1 Takara Bio Company Information
11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Takara Bio Main Business Overview
11.25.5 Takara Bio Latest Developments
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Information
11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Unum Therapeutics Main Business Overview
11.26.5 Unum Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Adoptive Cell Transfer Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK
Table 4. Major Players of LAK
Table 5. Major Players of DC
Table 6. Major Players of CIK
Table 7. Major Players of CTL
Table 8. Major Players of TIL
Table 9. Major Players of TCR-T
Table 10. Major Players of CAR-T
Table 11. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 13. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Table 14. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 15. Global Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 16. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Table 17. Global Adoptive Cell Transfer Therapy Revenue by Player (2020-2025) & ($ millions)
Table 18. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2025)
Table 19. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
Table 20. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 24. Global Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Table 25. Global Adoptive Cell Transfer Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 26. Global Adoptive Cell Transfer Therapy Revenue Market Share by Country/Region (2020-2025)
Table 27. Americas Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 28. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2020-2025)
Table 29. Americas Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Table 31. Americas Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Table 33. APAC Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 34. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Table 35. APAC Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 36. APAC Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 38. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2020-2025)
Table 39. Europe Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Adoptive Cell Transfer Therapy
Table 45. Key Market Challenges & Risks of Adoptive Cell Transfer Therapy
Table 46. Key Industry Trends of Adoptive Cell Transfer Therapy
Table 47. Global Adoptive Cell Transfer Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 48. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 49. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 50. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 51. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 52. Novartis AG Adoptive Cell Transfer Therapy Product Offered
Table 53. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Novartis AG Main Business
Table 55. Novartis AG Latest Developments
Table 56. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 57. Kite Pharma Adoptive Cell Transfer Therapy Product Offered
Table 58. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Kite Pharma Main Business
Table 60. Kite Pharma Latest Developments
Table 61. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 62. Pfizer Adoptive Cell Transfer Therapy Product Offered
Table 63. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 67. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 68. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Juno Therapeutics Main Business
Table 70. Juno Therapeutics Latest Developments
Table 71. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 72. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
Table 73. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Celgene Corporation Main Business
Table 75. Celgene Corporation Latest Developments
Table 76. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 77. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 78. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. CARsgen Therapeutics Main Business
Table 80. CARsgen Therapeutics Latest Developments
Table 81. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 82. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 83. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sorrento Therapeutics Main Business
Table 85. Sorrento Therapeutics Latest Developments
Table 86. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 87. Legend Biotech Adoptive Cell Transfer Therapy Product Offered
Table 88. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Legend Biotech Main Business
Table 90. Legend Biotech Latest Developments
Table 91. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 92. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
Table 93. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Atara Biotherapeutics Main Business
Table 95. Atara Biotherapeutics Latest Developments
Table 96. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 97. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
Table 98. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Aurora Biopharma Main Business
Table 100. Aurora Biopharma Latest Developments
Table 101. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 102. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
Table 103. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Autolus Therapeutics PLC Main Business
Table 105. Autolus Therapeutics PLC Latest Developments
Table 106. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 107. Bluebird Adoptive Cell Transfer Therapy Product Offered
Table 108. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bluebird Main Business
Table 110. Bluebird Latest Developments
Table 111. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 112. Carina Biotech Adoptive Cell Transfer Therapy Product Offered
Table 113. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Carina Biotech Main Business
Table 115. Carina Biotech Latest Developments
Table 116. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 117. Athenex Adoptive Cell Transfer Therapy Product Offered
Table 118. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Athenex Main Business
Table 120. Athenex Latest Developments
Table 121. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 122. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
Table 123. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business
Table 125. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
Table 126. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 127. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
Table 128. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Hengrui Yuanzheng Main Business
Table 130. Hengrui Yuanzheng Latest Developments
Table 131. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 132. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 133. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Eureka Therapeutics Main Business
Table 135. Eureka Therapeutics Latest Developments
Table 136. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 137. WuXi Juno Adoptive Cell Transfer Therapy Product Offered
Table 138. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. WuXi Juno Main Business
Table 140. WuXi Juno Latest Developments
Table 141. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 142. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
Table 143. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Shenzhen Inno Immunity Main Business
Table 145. Shenzhen Inno Immunity Latest Developments
Table 146. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 147. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
Table 148. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Shenzhen Binde Bio Main Business
Table 150. Shenzhen Binde Bio Latest Developments
Table 151. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 152. Kerui Bio Adoptive Cell Transfer Therapy Product Offered
Table 153. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 154. Kerui Bio Main Business
Table 155. Kerui Bio Latest Developments
Table 156. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 157. Adaptimmune Adoptive Cell Transfer Therapy Product Offered
Table 158. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 159. Adaptimmune Main Business
Table 160. Adaptimmune Latest Developments
Table 161. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 162. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
Table 163. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 164. Altor Bioscience Corporation Main Business
Table 165. Altor Bioscience Corporation Latest Developments
Table 166. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 167. Cellectis Adoptive Cell Transfer Therapy Product Offered
Table 168. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 169. Cellectis Main Business
Table 170. Cellectis Latest Developments
Table 171. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 172. Takara Bio Adoptive Cell Transfer Therapy Product Offered
Table 173. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 174. Takara Bio Main Business
Table 175. Takara Bio Latest Developments
Table 176. Unum Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 177. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 178. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 179. Unum Therapeutics Main Business
Table 180. Unum Therapeutics Latest Developments
Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Adoptive Cell Transfer Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK
Table 4. Major Players of LAK
Table 5. Major Players of DC
Table 6. Major Players of CIK
Table 7. Major Players of CTL
Table 8. Major Players of TIL
Table 9. Major Players of TCR-T
Table 10. Major Players of CAR-T
Table 11. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 13. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Table 14. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 15. Global Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 16. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Table 17. Global Adoptive Cell Transfer Therapy Revenue by Player (2020-2025) & ($ millions)
Table 18. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2025)
Table 19. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
Table 20. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 24. Global Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Table 25. Global Adoptive Cell Transfer Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 26. Global Adoptive Cell Transfer Therapy Revenue Market Share by Country/Region (2020-2025)
Table 27. Americas Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 28. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2020-2025)
Table 29. Americas Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Table 31. Americas Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Table 33. APAC Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 34. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Table 35. APAC Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 36. APAC Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Europe Adoptive Cell Transfer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 38. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2020-2025)
Table 39. Europe Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Adoptive Cell Transfer Therapy
Table 45. Key Market Challenges & Risks of Adoptive Cell Transfer Therapy
Table 46. Key Industry Trends of Adoptive Cell Transfer Therapy
Table 47. Global Adoptive Cell Transfer Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 48. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 49. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 50. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 51. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 52. Novartis AG Adoptive Cell Transfer Therapy Product Offered
Table 53. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Novartis AG Main Business
Table 55. Novartis AG Latest Developments
Table 56. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 57. Kite Pharma Adoptive Cell Transfer Therapy Product Offered
Table 58. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Kite Pharma Main Business
Table 60. Kite Pharma Latest Developments
Table 61. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 62. Pfizer Adoptive Cell Transfer Therapy Product Offered
Table 63. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 67. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 68. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Juno Therapeutics Main Business
Table 70. Juno Therapeutics Latest Developments
Table 71. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 72. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
Table 73. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Celgene Corporation Main Business
Table 75. Celgene Corporation Latest Developments
Table 76. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 77. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 78. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. CARsgen Therapeutics Main Business
Table 80. CARsgen Therapeutics Latest Developments
Table 81. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 82. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 83. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sorrento Therapeutics Main Business
Table 85. Sorrento Therapeutics Latest Developments
Table 86. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 87. Legend Biotech Adoptive Cell Transfer Therapy Product Offered
Table 88. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Legend Biotech Main Business
Table 90. Legend Biotech Latest Developments
Table 91. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 92. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
Table 93. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Atara Biotherapeutics Main Business
Table 95. Atara Biotherapeutics Latest Developments
Table 96. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 97. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
Table 98. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Aurora Biopharma Main Business
Table 100. Aurora Biopharma Latest Developments
Table 101. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 102. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
Table 103. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Autolus Therapeutics PLC Main Business
Table 105. Autolus Therapeutics PLC Latest Developments
Table 106. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 107. Bluebird Adoptive Cell Transfer Therapy Product Offered
Table 108. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Bluebird Main Business
Table 110. Bluebird Latest Developments
Table 111. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 112. Carina Biotech Adoptive Cell Transfer Therapy Product Offered
Table 113. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Carina Biotech Main Business
Table 115. Carina Biotech Latest Developments
Table 116. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 117. Athenex Adoptive Cell Transfer Therapy Product Offered
Table 118. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Athenex Main Business
Table 120. Athenex Latest Developments
Table 121. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 122. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
Table 123. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business
Table 125. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
Table 126. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 127. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
Table 128. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Hengrui Yuanzheng Main Business
Table 130. Hengrui Yuanzheng Latest Developments
Table 131. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 132. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 133. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Eureka Therapeutics Main Business
Table 135. Eureka Therapeutics Latest Developments
Table 136. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 137. WuXi Juno Adoptive Cell Transfer Therapy Product Offered
Table 138. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. WuXi Juno Main Business
Table 140. WuXi Juno Latest Developments
Table 141. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 142. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
Table 143. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Shenzhen Inno Immunity Main Business
Table 145. Shenzhen Inno Immunity Latest Developments
Table 146. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 147. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
Table 148. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Shenzhen Binde Bio Main Business
Table 150. Shenzhen Binde Bio Latest Developments
Table 151. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 152. Kerui Bio Adoptive Cell Transfer Therapy Product Offered
Table 153. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 154. Kerui Bio Main Business
Table 155. Kerui Bio Latest Developments
Table 156. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 157. Adaptimmune Adoptive Cell Transfer Therapy Product Offered
Table 158. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 159. Adaptimmune Main Business
Table 160. Adaptimmune Latest Developments
Table 161. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 162. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
Table 163. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 164. Altor Bioscience Corporation Main Business
Table 165. Altor Bioscience Corporation Latest Developments
Table 166. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 167. Cellectis Adoptive Cell Transfer Therapy Product Offered
Table 168. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 169. Cellectis Main Business
Table 170. Cellectis Latest Developments
Table 171. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 172. Takara Bio Adoptive Cell Transfer Therapy Product Offered
Table 173. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 174. Takara Bio Main Business
Table 175. Takara Bio Latest Developments
Table 176. Unum Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 177. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 178. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 179. Unum Therapeutics Main Business
Table 180. Unum Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Adoptive Cell Transfer Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cell Transfer Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Adoptive Cell Transfer Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Adoptive Cell Transfer Therapy Sales Market Share by Country/Region (2024)
Figure 8. Adoptive Cell Transfer Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2024
Figure 10. Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia
Figure 11. Global Adoptive Cell Transfer Therapy Market: Acute Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. Adoptive Cell Transfer Therapy in NHL
Figure 13. Global Adoptive Cell Transfer Therapy Market: NHL (2020-2025) & ($ millions)
Figure 14. Adoptive Cell Transfer Therapy in Melanoma
Figure 15. Global Adoptive Cell Transfer Therapy Market: Melanoma (2020-2025) & ($ millions)
Figure 16. Adoptive Cell Transfer Therapy in Bladder Cancer
Figure 17. Global Adoptive Cell Transfer Therapy Market: Bladder Cancer (2020-2025) & ($ millions)
Figure 18. Adoptive Cell Transfer Therapy in Lung Cancer
Figure 19. Global Adoptive Cell Transfer Therapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 20. Adoptive Cell Transfer Therapy in Head and Neck Cancer
Figure 21. Global Adoptive Cell Transfer Therapy Market: Head and Neck Cancer (2020-2025) & ($ millions)
Figure 22. Adoptive Cell Transfer Therapy in Multiple Myeloma
Figure 23. Global Adoptive Cell Transfer Therapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 24. Adoptive Cell Transfer Therapy in Other
Figure 25. Global Adoptive Cell Transfer Therapy Market: Other (2020-2025) & ($ millions)
Figure 26. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2024
Figure 27. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player in 2024
Figure 28. Global Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Figure 29. Americas Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 30. APAC Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 31. Europe Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 33. Americas Adoptive Cell Transfer Therapy Value Market Share by Country in 2024
Figure 34. United States Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2024
Figure 39. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 40. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 41. China Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. India Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country in 2024
Figure 48. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 49. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 50. Germany Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. France Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 64. APAC Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 65. Europe Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 67. United States Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 68. Canada Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 69. Mexico Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 70. Brazil Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 71. China Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 72. Japan Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 73. Korea Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 75. India Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 76. Australia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 77. Germany Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 78. France Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 79. UK Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 80. Italy Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 81. Russia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 82. Egypt Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 83. South Africa Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 84. Israel Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 85. Turkey Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 86. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 1. Adoptive Cell Transfer Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cell Transfer Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Adoptive Cell Transfer Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Adoptive Cell Transfer Therapy Sales Market Share by Country/Region (2024)
Figure 8. Adoptive Cell Transfer Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2024
Figure 10. Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia
Figure 11. Global Adoptive Cell Transfer Therapy Market: Acute Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. Adoptive Cell Transfer Therapy in NHL
Figure 13. Global Adoptive Cell Transfer Therapy Market: NHL (2020-2025) & ($ millions)
Figure 14. Adoptive Cell Transfer Therapy in Melanoma
Figure 15. Global Adoptive Cell Transfer Therapy Market: Melanoma (2020-2025) & ($ millions)
Figure 16. Adoptive Cell Transfer Therapy in Bladder Cancer
Figure 17. Global Adoptive Cell Transfer Therapy Market: Bladder Cancer (2020-2025) & ($ millions)
Figure 18. Adoptive Cell Transfer Therapy in Lung Cancer
Figure 19. Global Adoptive Cell Transfer Therapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 20. Adoptive Cell Transfer Therapy in Head and Neck Cancer
Figure 21. Global Adoptive Cell Transfer Therapy Market: Head and Neck Cancer (2020-2025) & ($ millions)
Figure 22. Adoptive Cell Transfer Therapy in Multiple Myeloma
Figure 23. Global Adoptive Cell Transfer Therapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 24. Adoptive Cell Transfer Therapy in Other
Figure 25. Global Adoptive Cell Transfer Therapy Market: Other (2020-2025) & ($ millions)
Figure 26. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2024
Figure 27. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player in 2024
Figure 28. Global Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Figure 29. Americas Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 30. APAC Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 31. Europe Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2020-2025 ($ millions)
Figure 33. Americas Adoptive Cell Transfer Therapy Value Market Share by Country in 2024
Figure 34. United States Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2024
Figure 39. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 40. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 41. China Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. India Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country in 2024
Figure 48. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 49. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 50. Germany Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. France Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Adoptive Cell Transfer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 64. APAC Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 65. Europe Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 67. United States Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 68. Canada Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 69. Mexico Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 70. Brazil Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 71. China Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 72. Japan Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 73. Korea Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 75. India Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 76. Australia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 77. Germany Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 78. France Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 79. UK Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 80. Italy Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 81. Russia Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 82. Egypt Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 83. South Africa Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 84. Israel Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 85. Turkey Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
Figure 86. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Adoptive Cell Transfer Therapy Market Size 2026-2031 ($ millions)
More Publications
Global Pre-Clinicals Stage Cardiovascular Pipeline Products Market Growth 2024-2030
US$ 3,660.00
February 2024
122 pages
Global Photoplethysmographs Market Growth 2023-2029
US$ 3,660.00
March 2023
99 pages
Global Hemoglobinometers Market Growth 2024-2030
US$ 3,660.00
November 2024
91 pages
